Scientific Program החברה הישראלית לכירורגיה אונקולוגית. The Israel Society of Surgical Oncology הכנס הדו שנתי של. The Biennial conference of
|
|
|
- Robyn Charlene Gallagher
- 5 years ago
- Views:
Transcription
1 הכנס הדו שנתי של החברה הישראלית לכירורגיה אונקולוגית The Biennial conference of The Israel Society of Surgical Oncology 7-9 February, 2018 Elma Hotel & Arts Complex Zichron Ya akov אלמא מלון ומרכז אומניות זכרון יעקב 2018, בפברואר 7-9 Scientific Program 1
2 Wednesday, February 7, :30-22:30 Dinner Session - The Cube Club Chairs: Y. Skornick, E. Klein, E. Mavor D. Coit - The Lymph Node E. Rutgers - Does Axillary Clearance Become an Obsolete in Breast Cancer Management? L. Ferri - Multimodal Therapy for Esophago-gastric Adenocarcinoma 2 3
3 08:00-09:00 09:00-09:20 09:20-11:00 09:20-09:50 09:50-10:30 10:30-11:00 Thursday, February 8, 2018 Registration, Morning Reception Greetings and Welcome Ceremony - Hall I H. Gutman, Y. Kluger, M. Ziv Opening Session 1 - Hall I Chairs - J. Klausner, S. Avital, G. Sebbag L. Ferri - The Influence of Post-operative Complications on Oncological Outcomes H. Haick - Cooperation between Volatile Biomarkers and Nanotechnology for Non-Invasive Monitoring of Health K. McMasters - Melanoma and Breast Micromets - Similarities and Differences Travel Supported by 4 11:00-11:30 11:30-14:00 11:30-12:00 12:00-12:30 12:30-13:00 13:00-13:30 Coffee Break and Exhibition Visit Session 2 - Hall I Chairs: M. Gutman, P. Reissman R. Pollock - A Possible First Biomarker for Dedifferentiated Liposarcoma of Retroperitoneum J. Schachter - Immunotherapy in the Treatment of Melanoma - Sponsored by D. Coit - Gastric Cancer Extent of Surgery Update in the Multidisciplinary Approach to Intestinal & Pancreatic Neuroendocrine Tumors - Symposium Sponsored by Intestinal Neuroendocrine Tumors - S. Glasberg Pancreatic Neuroendocrine Tumors - E. Sadot 5
4 13:30-14:30 14:30-16:30 14:30-15:00 14:30-14:50 14:50-15:00 Lunch Break Session 3 - Hall I Chairs: J. Zidan, T. Allweis, M. Koretz Optimizing Treatment in HER2+ Early Breast Cancer - A Multidisciplinary Approach - Symposium Sponsored by S. Paluch-Shimon - Medical M. Carmon - Surgical 15:00-16:30 15:00-15:30 15:30-16:00 Parallel Session - Hall I Session 3 Continued E. Rutgers - De-escalation of Surgery in Breast Cancer after Neo Adjuvant Debate: Completion Lymph Node Dissection for Micrometastasis in Melanoma Chairs: E. Shiloni, R. Lavy For - M. Gutman Against - K. McMasters Travel Supported by Mediator - S. Schneebaum 16:00-16:15 16:15-16:30 M.A. Kiladze - Optimal Management Strategy for Favourable Outcomes at Whipples Operation C. Gatnadze - Clinical Analysis of Surgical Management of the Reccurrent Gynecological Tumors: Lessons Learned 6 7
5 15:00-16:20 15:00-16:20 15:00-15:20 15:20-15:40 15:40-16:00 16:00-16:20 Parallel Session - Hall II IPMN Chairs: E. Kakiashvili, Y. Solomonov, D. Kopelman A. Dancour - Endoscopic Ultrasound for Evaluation and Diagnosis of IPMN N. Goldberg - CT and MRI Imaging for IPMN N. Lubetzki - Surgical Approach to IPMN B. Bar-Zakai - Case Presentations 16:30-17:00 17:00-19:30 Coffee Break and Exhibition Visit Session 4 - Free Paper Presentations (5 minute presentations) - Hall I Chairs: H. Paran, D. Aronovich, O. Zmora Post Operative Complication after Lumpectomy with Intra Operative Radiation Therapy H. Kadar Sfarad Intra-Operative Radiation for Breast Cancer- Short Term Results I. Melnik Breast Tissue Dynamics in BRCA1/2 Mutation Carriers O. Arieli The Impact of Immediate Breast Reconstruction on the Initiation of Adjuvant Chemotherapy B. Helou 8 9
6 Free Paper Presentations - Hall I The 21 Gene Assay (Oncotype Dx) as a Decision Aid in Patients with Breast Cancer prior to Surgery A. Wachtel Anxiety in Breast Cancer Patients prior to Neoadjuvant Therapy is Higher Compared to those Referred Directly to Surgery S. Kreitler Impact of Delaying Initiation of Adjuvant Chemotherapy and Trastuzumab in Patients with Early Stage HER2 Positive Breast Cancer S. Anani Long Term Follow up of Patients with Pathological Complete Response following Neoadjuvant Chemoradiation for Esophageal Cancer Y. Feferman Surgery for Stage IV Visceral Malignant Melanoma O. Friedman-Eldar Failure to Identify Sentinel Lymph Nodes for Malignant Melanoma Outcome after Over 10 Years Median Follow-up O. Zlotnik 10 Free Paper Presentations - Hall I Patterns of Failure in Patients with Head and Neck Melanoma S. Tzelnick Video Presentation: Laparoscopic Pancreaticodoudenectomy A Single Institution Experience C. Shwaartz Senescent Cells provide Essential Support to Pancreatic Precancerous Lesion Growth and Progression through Cox2 Activity J. Rachmuth Preliminary Results in Developing a Geriatric Prognostic Assessment Tool for Elderly Patients with Colon and Rectal Cancer L. Cooper Unique Phenotype of Colorectal Cancer in BRCA1/2 Mutation Carriers A. Grinshpun 11
7 Free Paper Presentations - Hall I Initial Experience with Neoadjuvant FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer: An Intention to Treat Analysis N. Lubezky No Response to Neo-adjuvant Radiotherapy (TRS 3*) is Associated with Increased Cancer Recurrence, Particularly Distant, in Patients undergoing Neoadjuvant Radiotherapy for Rectal Cancer L. Lahav Detection of Long Intervening Non-coding RNA - CCAT1 Colorectal Cancer Biomarker in Living Cells and Human Biopsies by Forced Intercalation - Peptide Nucleic Acids (FIT- PNAs) R. Shapira Management of Recurrent Adenocarcinoma of the Rectum: A Single Center Experience A. Ben-Yaacov 12 Omental Exosomes Promote Gastric Cancer Aggressiveness: A Potential Novel Mechanism of Gastric Cancer Peritoneal Metastasis G. Lahat Initial Experience with Laparoscopic D2 Gastrectomy for Gastric Cancer B. Raguan Schneidman 18:30-19:30 18:30-18:50 18:50-19:30 19:30 Free Paper Presentations - Hall I Cheese & Wine Event Sponsored by Meet the Expert on Targeted Therapy for Melanoma - Hall II Chair: G. Bar Sela H. Gogas - Overview of Current and Future Clinical Studies regarding Combination Targeted Therapy for Melanoma Case Presentations and Discussion Get Together Cocktail Sponsored by 13
8 Friday, February 9, :00-09:00 Registration, Morning Reception 08:30-13:30 08:30-09:30 Parallel Sessions Hall I Pre-morning Session - Free Paper Presentations (5 minute presentations) Chairs: G. Lahat, B. Sagi, N. Menasherov Urologic Involvement and Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy A. Dori Preoperative Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio Predict overall Survival in Colorectal Cancer Patients that are Candidates for CRS+HIPEC Y. Zager Repeated Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-our Experience S. Goren 14 Free Paper Presentations - Hall I Cytoreductive Surgery and Hyperthermic Intra Peritoneal Chemotherapy (HIPEC): Lessons Learned from 337 Consecutive Patients A. Ben-Yaacov Implementation of a Hyperthermic Intraperitoneal Chemotherapy Program How to Minimize the Learning Curve V. Tverskov Cytoreductive Surgery and HIPEC in the Elderly A. Bilik Acute Post-operative Hypoalbuminemia Predicts Prognosis following CRS-HIPEC M. Cordoba MRI Diagnosis and Follow-up of Chest Wall and Breast Desmoid Tumors in Patients with a History of Oncologic Breast Surgery and Silicone Implants: A Pictorial Report A. Grubstein 15
9 Free Paper Presentations - Hall I Doxorubicin Eluting Intra-arterial Therapy for Extra Abdominal Desmoid Fibromatosis: A Promising Approach for a Perplexing Disease E. Elnekave Comparison of Classic Anastomosis Vs Roux en Y Anastomosis in Pancreaticoduodenectomy O. Yzhaky Shapira Dual Loop (Roux en Y) Reconstruction with Isolated Gastric Limb Reduce the Rates of Delayed Gastric Emptying in Patients undergoing Pancreatico-duodenectomy O. Ben-Ishay 09:30-11:00 09:30-09:40 Morning Session 5 - Hall I Chairs: A. Eid, R. Haddad, H. Kashtan I. Avital - Building-up a Cancer Center in Soroka 10:00-10:40 10:40-11:00 11:00-11:30 11:30-12:50 11:30-12:00 12:00-12:20 Rami Czerniak Memorial Lecture: R. Adam - Multidisciplinary Management of Liver Colorectal Metastases A. Zer - New Horizons for GIST Coffee Break and Exhibition Visit Session 6 - Further Debates Chairs: D. Benchimol, B. Bar-Zakai, A. Pikarski Debate: Resection or Ablation of Liver Metastasis Resection - M. Ben Haim (10') Ablation - L. Appelbaum (10') Mediator - R. Adam (5') & Q&A (5') M. Deraco - Peritoneal Mesothelioma Parallel Sessions - Hall I 09:40-10:00 N. Peled - Precision Medicine in Lung Cancer 16 17
10 Parallel Sessions - Hall I 12:20-12:50 12:50-13:30 Debate: Role of Cytoreductive (HIPEC) in GI Malignancies For - A. Nissan (10') Against - D. Coit (10') Mediator - D. Benchimol (5') & Q&A (5') Closing Remarks, Professional Meeting, Treasurer Report, Elections for Chairman The Israeli Society of Breast Diseases Annual Meeting 08:30-13:15 08:30-10:20 08:30-08:40 Parallel Sessions - Hall II Neoadjuvant Treatment S. Schneebaum, M. Ziv - Introductions 14:00-14:30 Lunch 08:40-10:35 08:40-09:00 09:00-09:20 Chairs: M. Inbar, T. Peretz, M. Koretz Tailoring Individual Treatment T. Allweis - Oncotype Dx E. Evron - Hormonal Neoadjuvant 09:20-09:35 G. Fried - Her 2 Neoadjuvant 09:35-09:50 R. Yerushalmi - Triple Negative Neoadjuvant 18 19
11 Parallel Sessions - Hall II 09:50-10:15 10:15-10:35 10:35-12:00 10:35-11:00 11:00-11:30 Marking the Sentinel Nodes: Coal - T. Allweis Clip - M. Carmon S. Gelper - Radiotherapy Treatment of Complete Response in the Axilla Chairs: T. Menes, D. Hershko, O. Golan K. McMasters - Treatment of Liver Metastases from Breast Cancer Travel Supported by Coffee Break and Exhibition Visit 12:00-13:15 12:00-12:30 12:30-12:50 12:50-13:15 14:00-14:30 Chairs: L. Ribo, R. Ben Yoseph M. Toker - Advances in Treatment of ER Positive Metastatic Breast Cancer - Sponsored by A. Yosepovich - Histological Assessment of Response to Neoadjuvant E. Bar Meir & A. Tessone - Is Radiation a Contra Indication to Immediate Reconstruction? Lunch Parallel Sessions - Hall II 11:30-12:00 M. Sclair & T. Sela - Radiological Assessment of Response MRI Always Yes/No Remove all Calcifications Yes/No 20 21
12 Notes 22 23
13 Platinum Sponsor Gold Sponsors Silver Sponsors Exhibitors ארגון והפקה: טלפון :
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.
Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: SURGICAL ONCOLOGY 5-May-2013 DEVELOPED BY: Bruce
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated
Mayo Clinic Interactive Surgery Symposium 2018 Program Schedule
Mayo Clinic Interactive Surgery Symposium 2018 Program Schedule Sunday, February 18, 2018 11:30 Registration & Continental Breakfast COLORECTAL Ron G. Landmann, M.D. 12:30 p.m. Welcome Announcements and
What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine
What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Layman s terms: cancer starts when cells grow out of control (in any place in the body) and crowd out normal cells
Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R
Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R 2 0 1 2 Objectives Discuss Diagnostic and staging strategies in oncology Know
Ines Buccimazza 16 TH UP CONTROVERSIES AND PROBLEMS IN SURGERY SYMPOSIUM
BILATERAL MASTECTOMY IS NOT ROUTINELY JUSTIFIED IN PATIENTS WITH BILATERAL AXILLARY LYMPHADENOPATHY AND ONLY ONE DETECTABLE PRIMARY BREAST CANCER LESION SURGERY SYMPOSIUM Ines Buccimazza Breast Unit Department
Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)
Pancreas Quizzes Quiz 1 1. The pancreas produces hormones. Which type of hormone producing organ is the pancreas? a. Endocrine b. Exocrine c. Both A and B d. Neither A or B 2. Endocrine indicates hormones
ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:
1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications
ISRAELI NEUROENDOCRINE TUMORS PROGRAM
th THE 4 1 ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 11.10.2018-13.10.2018 Crown Plaza Hotel, the Dead Sea PROGRAM Thursday, 11.10.2018 15:00-15:30 Registration 15:30-15:50 Opening Remarks 15:50-16:50
is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the
My name is Barry Feig. I am a Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. I am going to talk to you today about the role for surgery in the treatment
Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
Surgical Management of Pancreatic Cancer
I Congresso de Oncologia D Or July 5-6, 2013 Surgical Management of Pancreatic Cancer Michael A. Choti, MD, MBA, FACS Department of Surgery Johns Hopkins University School of Medicine, Baltimore, MD Estimated
Breast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012
Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt
Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,
Breast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina
Breast Imaging: Multidisciplinary Approach Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina No Disclosures Objectives Discuss a multidisciplinary breast
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, pancreatic ductal, laparoscopic distal pancreatectomy for, 61 Adrenal cortical carcinoma, laparoscopic adrenalectomy for, 114
PRELIMINARY PROGRAM. 11 th International Workshop on Peritoneal Surface Malignancy SEPTEMBER 9-11,
11 th International Workshop on Peritoneal Surface Malignancy PRELIMINARY PROGRAM SEPTEMBER 9-11, 2018 Maison de la Chimie, Paris, France www.psogi2018.com 9THSATURDAY 8TH 2SUNDAY Saturday, September 8
Colorectal Cancer Multidisciplinary management, standards of care and future perspectives
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves
Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?
Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen
April 26 th April 29 th, 2017 Kibbutz Hagoshrim, Israel WEDNESDAY, APRIL 26, rd International Congress on Molecular Targeting Therapy
3 rd International Congress on Molecular Targeting Therapy April 26 th April 29 th, 2017 Kibbutz Hagoshrim, Israel WEDNESDAY, APRIL 26, 2017 Update: Mar. 12 14:00-21:00 Registration & Check-In 16:00-17:00
PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018
PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, 2018 16 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 12-15, 2018 Friday, January 12, 2018 Registration:
11/21/13 CEA: 1.7 WNL
Case Scenario 1 A 70 year-old white male presented to his primary care physician with a recent history of rectal bleeding. He was referred for imaging and a colonoscopy and was found to have adenocarcinoma.
Steamboat Springs, Colorado. January 15-18, 2016
Friday, January 15, 2016 Registration: Begins at 2:00 pm Plenary Session: 4:00 pm - 6:00 pm 14 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 15-18, 2016 Current Status
GRAZ TUTORIAL. Education in partnership. October Graz/Austria. myesr.org/esor
Education in partnership Programme Monday, October 16, 2017 08:00 08:30 Registration 08:30 09:00 Opening H. Samonigg, Graz/AT Rector of Medical University Graz G. Brunner, Graz/AT Medical Director of University
Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015
Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable
Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.
Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to
RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES
RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES At the completion of Breast Fellowship training, the
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, for early-stage triple-negative breast cancer, 740 742 in older early-stage breast cancer patients, 790 795 anti-her2-directed
It is a malignancy originating from breast tissue
59 Breast cancer 1 It is a malignancy originating from breast tissue including both early stages which are potentially curable, and metastatic breast cancer (MBC) which is usually incurable. Most breast
PRECEPTORSHIP PROGRAMME
esmo.org PRECEPTORSHIP PROGRAMME Gastrointestinal Tumours Multidisciplinary management, standards of care and future perspectives SINGAPORE 20-22 OCTOBER 2016 Co-Chairs Jean-Yves Douillard, Switzerland
Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic
Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic cancer Section AA Cancer Centre Referrals In the absence of metastatic
Crown Plaza Hotel, the Dead Sea PROGRAM
1 THE 4 th ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 11.10.2018-13.10.2018 Crown Plaza Hotel, the Dead Sea PROGRAM Thursday, 11.10.2018 15:00-15:30 Registration 15:30-15:50 Opening Remarks: Dr. Simona
PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
Breast Cancer Diagnosis, Treatment and Follow-up
Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce
DEPARTMENT OF ONCOLOGY ELECTIVE
DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:
COLON AND RECTAL CANCER
COLON AND RECTAL CANCER Mark Sun, MD Clinical Associate Professor of Surgery University of Minnesota No disclosures Objectives 1) Understand the epidemiology, management, and prognosis of colon and rectal
:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B
04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture
CT PET SCANNING for GIT Malignancies A clinician s perspective
CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset
Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer
Ovarian cancer Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer JM. Classe, R. Rouzier, O.Glehen, P.Meeus, L.Gladieff, JM. Bereder, F Lécuru Suitable candidates for neo-adjuvant
Shift your surgical ambition to surgical action
Dates: February 1-3, 2018 3th International Meeting ENDO-Dubai : Updates in Minimal Invasive surgery in Gynecology Shift your surgical ambition to surgical action AGENDA AT A GLANCE Thursday, February
IJC International Journal of Cancer
IJC International Journal of Cancer Short Report Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer Naama Halpern 1, Amir Sonnenblick 2,
Preliminary Programme
Preliminary Programme THURSDAY 26 April 2018 08.15-09.00 Registration desk 09.00-09.10 Welcome Address: Update in Breast Imaging B. Claikens (Ostend, BE) SESSION 1 Chairman : R. Pijnappel (Nijmegen, NED)
RAISING THE BAR IN BREAST CANCER CARE
RAISING THE BAR IN BREAST CANCER CARE Multidisciplinary Approach in Breast Cancer October 26 th, 2018 Dan Hotel, Tel-Aviv HER2+ ER+ HER2- TNBC luminal B luminal A Joseph Gligorov, MD Professor of Medicine
Cancer of Unknown Primary (CUP) Protocol
1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date
Hematology, Oncology & Blood & Marrow Transplant for NPs & PAs
PHARMACOLOGY CONTENT Hematology, Oncology & Blood & Marrow Transplant for NPs & PAs Select presentations will contain pharmacology content as noted in the program. Identified presentations represent approximately
Interactive Staging Bee
Interactive Staging Bee ROBIN BILLET, MA, CTR GA/SC REGIONAL CONFERENCE NOVEMBER 6, 2018? Clinical Staging includes any information obtained about the extent of cancer obtained before initiation of treatment
Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015
Advances in Breast Surgery Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Objectives Understand the surgical treatment of breast cancer Be able to determine when a lumpectomy
Cancer Endorsement Maintenance 2011-Maintenance Measures
Measure Number Title Description Measure Steward 0210 Proportion receiving chemotherapy in the last 14 days of life 0211 Proportion with more than one emergency room visit in the last days of life 0212
SCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017
Friday 1 st September 1300h 1400h Lunch (arrival, registration at conference foyer, coffee and sponsors exhibition) 1400h 1420h Prof Robert Jones Welcome/Announcements 1430h 1600h Parallel sessions: Lung
Radiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
Treatment of gastrointestinal cancer. General considerations International guidelines
Treatment of gastrointestinal cancer General considerations International guidelines Therapeutical options Chemotherapy Moleculary targeted therapy Irradiation Immunotherapy Radiological intervention Oncosurgery
Multidisciplinary management of retroperitoneal sarcomas
Multidisciplinary management of retroperitoneal sarcomas Eric K. Nakakura, MD UCSF Department of Surgery UCSF Comprehensive Cancer Center San Francisco, CA 7 th Annual Clinical Cancer Update North Lake
HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies
HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies Crescent City Cancer Update: GI and HPB Saturday September 24, 2016 George M. Fuhrman,
ISHNOS November Pastoral Hotel, Israel. The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology
The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology ISHNOS 2018 www.ishnos.com Conference Secretariat Umbrella Events E-mail: umbrella.inquiry@gmail.com www.umbrella-events.com
THORACIC MALIGNANCIES
THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,
Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging
Saturday, November 5, 2005 8:30-10:30 a. m. Poorly Differentiated Endocrine Carcinomas Chairman: E. Van Cutsem, Leuven, Belgium 9:00-9:30 a. m. Working Group Sessions Pathology and Genetics Group leaders:
Page 1. AHN-JHU Breast Cancer Symposium. Novel Local Regional Clinical Trials. Background. Neoadjuvant Chemotherapy Benefit.
AHN-JHU Breast Cancer Symposium Novel Local Regional Clinical Trials March 22, 2019 Thomas B. Julian, MD, FACS Associate Medical Director, Cancer Program Development, ANH Cancer Institute Background In
Updates on management of the axilla in breast cancer the surgical point of view
Updates on management of the axilla in breast cancer the surgical point of view Edwige Bourstyn Centre des maladies du sein Hôpital Saint Louis Paris Sentinel lymph node biopsy (SLNB) is the standard of
Pre-operative assessment of patients for cytoreduction and HIPEC
Pre-operative assessment of patients for cytoreduction and HIPEC Washington Hospital Center Washington, DC, USA Ovarian Cancer Surgery New Strategies Bergamo, Italy May 5, 2011 Background Cytoreductive
Index. Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, Anorectal melanoma RT for, 1035
Index Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, 947 948 Anorectal melanoma RT for, 1035 B Bacille Calmette-Guerin (BCG) in melanoma, 1008 BCG. See Bacille
Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology
BREAST CANCER 24 Breast Cancer Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by William J. Gradishar, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern
Causation Issues. Delay in Diagnosis of Cancer Cases. Prof Pat Price Imperial College London
Causation Issues Delay in Diagnosis of Cancer Cases Prof Pat Price Imperial College London office@patprice.co.uk www.patprice.co.uk Faculty of Advocates Annual conference 18 th June 2018 EVIDENCE BASED
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal surgery prior as factor in laparoscopic colorectal surgery, 554 555 Abscess(es) CRC presenting as, 539 540 Adenocarcinoma of
Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies
Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service City of Hope Division of Surgical Oncology September
Classification System
Classification System A graduate of the Breast Oncology training program should be able to care for all aspects of disease and/or provide comprehensive management. When referring to a discipline of training
Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201
Patient Presentation 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201 CT shows: Thickening of the right hemidiaphragm CT shows: Fluid in the right paracolic sulcus CT shows: Large
Prostate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
Quiz. b. 4 High grade c. 9 Unknown
Quiz 1. 10/11/12 CT scan abdomen/pelvis: Metastatic liver disease with probable primary colon malignancy. 10/17/12 Colonoscopy with polypectomy: Adenocarcinoma of sigmoid colon measuring at least 6 mm
COLON AND RECTAL CANCER
No disclosures COLON AND RECTAL CANCER Mark Sun, MD Clinical Assistant Professor of Surgery University of Minnesota Colon and Rectal Cancer Statistics Overall Incidence 2016 134,490 new cases 8.0% of all
Breast Cancer Breast Managed Clinical Network
Initial Evaluation Clinical Stage Pre-Treatment Evaluation Treatment and pathological stage Less than 4 positive lymph nodes Adjuvant Treatment ER Positive HER2 Negative (see page 2 & 3 ) HER2 Positive
Navigators Lead the Way
RN Navigators Their Role in patients with Cancers of the GI tract Navigators Lead the Way Nurse Navigator Defined Nurse Navigator A clinically trained individual responsible for the identification and
GALEN ADVANCED Course
YEAR OF ESOR YEAR OF ESOR GALEN ADVANCED Course Education in partnership Course information This course is aimed at senior residents, board-certified radiologists and fellows interested in abdominal imaging.
Maria João Cardoso, MD, PhD
Locally Advanced Breast Cancer Specific Issues in LocorregionalTreatment Surgery, MD, PhD Head Breast Surgeon Breast Unit, Champalimaud Foundation Lisbon, Portugal 1 Conflict of Interest Disclosure No
MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER
MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction
3 rd Berlin Cancer Retreat - Agenda
3 rd Berlin Cancer Retreat - Agenda Wednesday, 5 October 2016 8:30 9:00 Registration 9:00 9:10 Welcome and Introduction Program Exploitation of Oncogenic Mechanisms Ulrike Stein 9:10 9:25 Targeting Myc
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
NATIONAL QUALITY FORUM
Cancer Endorsement Maintenance Table of Submitted Measures Phase I 0210 1 Proportion receiving chemotherapy in the last 14 days of life Percentage of patients who died from cancer receiving chemotherapy
Staging Colorectal Cancer
Staging Colorectal Cancer CT is recommended as the initial staging scan for colorectal cancer to assess local extent of the disease and to look for metastases to the liver and/or lung Further imaging for
Surgical Therapy: Sentinel Node Biopsy and Breast Conservation
Surgical Therapy: Sentinel Node Biopsy and Breast Conservation Stephen B. Edge, MD Professor of Surgery and Oncology Roswell Park Cancer Institute University at Buffalo Dr. Roswell Park: Tradition in Cancer
Exercise 15: CSv2 Data Item Coding Instructions ANSWERS
Exercise 15: CSv2 Data Item Coding Instructions ANSWERS CS Tumor Size Tumor size is the diameter of the tumor, not the depth or thickness of the tumor. Chest x-ray shows 3.5 cm mass; the pathology report
ADVANCES IN SURGERY INDEX. who should have or not have axillary node dissection with, 1 18
Advances in Surgery 46 (2012) 297 301 ADVANCES IN SURGERY A Abdominal aortic aneurysms, medical screening for, 102 multivariate risk score, 106 repair of, readmission rates following, 166 167 ruptured,
Results of the ACOSOG Z0011 Trial
DCIS and Early Breast Cancer Symposium JUNE 15-17 2012 CAPPADOCIA Results of the ACOSOG Z0011 Trial Kelly K. Hunt, M.D. Professor of Surgery Axillary Node Dissection Staging, Regional control, Survival
CLINICAL ONCOLOGY 3 RD BALKAN AND EASTERN EUROPEAN MASTERCLASS IN May 2013 Dubrovnik, Croatia. Chair: R. Popescu, CH/RO Co-chair: S.
MASTERCLASS 3 RD BALKAN AND EASTERN EUROPEAN MASTERCLASS IN CLINICAL ONCOLOGY 8-12 May 2013 Dubrovnik, Croatia Chair: Co-chair: S. Beslija, BA Aims and objectives This clinically oriented residential educational
Anaplastic A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.
Oncology Terminology A Adenocarcinoma A cancerous tumor that arises in or resembles glandular tissue. Adjunct agent In cancer therapy, a drug or substance used in addition to the primary therapy. Adjuvant
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme 14-19 July 2016, Valencia, Spain Co-chairs: Andrés Cervantes, ES - Nicholas Pavlidis, GR - Susana Banerjee, UK Thursday, 14
Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)
Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018) I. Coordination of Care - 26% A. Breast health, screening, early detection, risk assessment and reduction 1. Issues related to
PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
Appendix ZOOM Etude pour site internet
Appendix ZOOM Etude pour site internet Indication Traitement adjuvant pour des patients présentant une mutation germinale des gènes BRCA1/2 et un risque élevé de cancer du sein primaire HER2 négatif Title
Educator Navigation Guide
Decoding Breast Cancer Virtual Lab Educator Navigation Guide Decoding Cancer Nav Guide 2 Introduction In this virtual lab, students test tissue samples from different patients with breast cancer in order
The Clinical Research E-News
The Clinical Research E-News Volume 7: ISSUE 1: January 16, 2015 Jefferson Kimmel Cancer Center Network: For urgent clinical trial questions or assistance please page: 877-656-9004 New Featured Trials
Oncotype DX testing in node-positive disease
Should gene array assays be routinely used in node positive disease? Yes Christy A. Russell, MD University of Southern California Oncotype DX testing in node-positive disease 1 Validity of the Oncotype
Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
A superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery.
1- A 63-year-old woman presents with a non-healing lesion on her right temple that has been present for over two years. On examination there is a 6 mm well defined lesion with central ulceration, telangiectasia
RAISING THE BAR IN BREAST CANCER CARE
RAISING THE BAR IN BREAST CANCER CARE Multidisciplinary Approach in Breast Cancer October 20th, 2017 Dan Hotel, Tel-Aviv HER2+ ER+ HER2- TNBC luminal B luminal A בחסות חברת רוש פרמצבטיקה )ישראל( בע"מ Kimberly
ASKLEPIOS Course MULTIDISCIPLINARY APPROACH TO CANCER IMAGING. Education in partnership. November 5 6, 2018 Rome/Italy. myesr.
ASKLEPIOS Course APPROACH TO CANCER IMAGING Education in partnership myesr.org/esor myesr.org/esor ASKLEPIOS Course APPROACH ASKLEPIOS Course Course information This course is designed for radiologists,
9th INTERNATIONAL TRAINING COURSE.
9th INTERNATIONAL TRAINING COURSE. MINIMALLY INVASIVE TRANSANAL SURGERY (TEO and TaTME). THE APPLICATION OF INDOCYANINE GREEN 12-13-14 December 2018 Colorectal Unit Parc Tauli University Hospital Sabadell
Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior